Skip Navigation


American Journal of Epidemiology Advance Access originally published online on August 6, 2008
American Journal of Epidemiology 2008 168(6):602-610; doi:10.1093/aje/kwn174
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
168/6/602    most recent
kwn174v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jiang, R.
Right arrow Articles by Barr, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, R.
Right arrow Articles by Barr, R. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology © The Author 2008. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

ORIGINAL CONTRIBUTIONS

Inflammatory Markers and Longitudinal Lung Function Decline in the Elderly

Rui Jiang1, Gregory L. Burke2, Paul L. Enright3, Anne B. Newman4, Helene G. Margolis5, Mary Cushman6,7, Russell P. Tracy7, Yuanjia Wang8, Richard A. Kronmal9 and R. Graham Barr1,10

1 Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY
2 Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC
3 Department of Medicine, University of Arizona, Tucson, AZ
4 Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA
5 Department of Internal Medicine, School of Medicine, University of California, Davis, CA
6 Department of Medicine, University of Vermont, Burlington, VT
7 Department of Pathology, University of Vermont, Burlington, VT
8 Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
9 Collaborative Health Studies Coordinating Center and Department of Biostatistics, University of Washington, Seattle, WA
10 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY

Correspondence to Dr. R. Graham Barr, Columbia University Medical Center, 622 West 168th Street, PH 9 East - Room 105, New York, NY 10032 (e-mail: rgb9{at}columbia.edu).

Received for publication January 9, 2008. Accepted for publication May 21, 2008.

Longitudinal studies examining associations of the inflammatory markers fibrinogen and C-reactive protein (CRP) with lung function decline are sparse. The authors examined whether elevated fibrinogen and CRP levels were associated with greater longitudinal lung function decline in the elderly. The Cardiovascular Health Study measured fibrinogen and CRP in 5,790 Whites and African Americans from four US communities aged 65 years or older in 1989–1990 or 1992–1993. Spirometry was performed in 1989–1990 and 4, 7, and 16 years later. Fibrinogen and CRP were inversely associated with lung function at baseline after adjustment for multiple potential confounders. In mixed models, the rate of decline in forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio with increasing age was faster among those with higher baseline fibrinogen (–0.032%/year per standard deviation higher fibrinogen (95% confidence interval: –0.057, –0.0074)) but not among those with higher CRP (–0.0037%/year per standard deviation higher CRP (95% confidence interval: –0.013, 0.0056)). Longitudinal analyses for FEV1 and FVC yielded results in the direction opposite of that hypothesized, possibly because of the high mortality rate and strong inverse association of FEV1 and FVC but not FEV1/FVC with mortality. An alternative approach to missing data yielded similar results. In conclusion, higher levels of fibrinogen, but not CRP, independently predicted greater FEV1/FVC decline in the elderly.

aged; biological markers; C-reactive protein; fibrinogen; forced expiratory volume; inflammation; spirometry; vital capacity


Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
J. A. Nettleton, J. L. Follis, and M. B. Schabath
Coffee Intake, Smoking, and Pulmonary Function in the Atherosclerosis Risk in Communities Study
Am. J. Epidemiol., June 15, 2009; 169(12): 1445 - 1453.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G Engstrom, N Segelstorm, M Ekberg-Aronsson, P M Nilsson, F Lindgarde, and C-G Lofdahl
Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study
Thorax, March 1, 2009; 64(3): 211 - 215.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.